| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $429.8M | +67.4% |
| R&D Expense | $88.8M | +11.6% |
| SG&A Expense | $129.3M | +5.7% |
| Pre-tax Income | -$229.8M | +22.0% |
| Income Tax | $7.1M | +136.7% |
| Net Income | -$236.9M | +20.4% |
| EPS (Basic) | -$3.40 | +25.9% |
| EPS (Diluted) | -$3.40 | +25.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $264.5M | -6.4% |
| Short-term Investments | $45.8M | -54.1% |
| Total Assets | $1.63B | -3.4% |
| Total Liabilities | $924.4M | +12.2% |
| Stockholders' Equity | $708.9M | -18.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$119.1M | +26.9% |
| Capital Expenditures | $9.2M | -8.9% |
| Investing Cash Flow | $88.7M | -51.0% |
| Financing Cash Flow | $15.4M | +327.8% |
| Free Cash Flow | -$128.3M | +25.9% |